Factors influencing Blacks and Whites participation in Alzheimers disease biomarker research
Eliacin, J.; Hathaway, E.; Wang, S.; O'Connor, C.; Saykin, A.; Cameron, K.
Show abstract
INTRODUCTIONAlzheimers disease (AD) is a public health priority. AD biomarkers may vary based on race, but recruitment of diverse participants has been challenging. METHODSThree groups of Black and White participants with and without prior research advocacy or participation were interviewed individually or in focus groups to better understand perspectives related to AD biomarker research participation. Thematic analytic approach was used to analyze the data. RESULTSIdentified barriers to AD biomarker research participation included hesitancy due to fear, distrust of research and researchers, lack of relevant knowledge, and lack of research test results disclosure. Drivers for engagement in biomarker research procedures included knowledge about research, AD, and related clinical procedures, perceived benefits of participation, and outreach from trusted sources. DISCUSSIONParticipants comments related to the need for diversity in research and desire for results disclosure suggest opportunities to engage Black individuals.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Qualitative Study of People with Alzheimer’s Disease in a Memory Clinic Considering Lecanemab Treatment 96%
- Association between motor task acquisition and hippocampal atrophy across cognitively unimpaired, amnestic Mild Cognitive Impairment, and Alzheimer’s disease individuals 91%
- Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13 91%
Similar papers in this journal
- The Healthy Brain Initiative (HBI): A prospective cohort study protocol 94%
- Randomized Clinical Trial of ICECaP (Individualized Coordination and Empowerment for Care Partners of Persons with Dementia): Primary Mental Health and Burden Outcomes 92%
- Top-funded digital health companies offering lifestyle interventions for dementia prevention: Company overview and evidence analysis 92%
Similar papers in this journal
- Association of Item-Level Responses to Cognitive Function Index with Tau Pathology and Hippocampal volume in The A4 Study 93%
- Racial/Ethnic Differences in Neuropsychological Test Performance in Frontotemporal Degeneration 91%
- Online46: online cognitive assessments in elderly cohorts - the British 1946 birth cohort case study 91%
Similar papers in this journal
- Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE) 95%
- The New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol 91%
- Digital Health Technologies for Metabolic Disorders in Older Adults: A Scoping Review Protocol 91%
Similar papers in this journal
- Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review 93%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 93%
- Real-world datasets for the International Registry for Alzheimer’s Disease and Other Dementias (InRAD) and other registries: an international consensus 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.